Literature DB >> 12946096

Social outcome in early psychosis.

J Addington1, J Young, D Addington.   

Abstract

BACKGROUND: It has been demonstrated that patients experiencing their first-episode of psychosis have social functioning deficits that are equivalent to those seen in patients with a more chronic course of illness. The purpose of this study is to examine social functioning over the course of the first year after admission to an early psychosis programme.
METHOD: The social functioning of 177 first-episode subjects was assessed on admission and 1 year later and compared with that of 40 non-psychiatric controls. Assessment measures included the Quality of Life Scale (QLS).
RESULTS: At the 1-year follow-up there was significant improvement in quality of life. However, even those first-episode patients experiencing a remission from positive symptoms had lower QLS scores than the non-psychiatric controls.
CONCLUSIONS: These results are encouraging and supportive of early intervention. There is room for more improvement in the application and development of psychological interventions for these young patients.

Entities:  

Mesh:

Year:  2003        PMID: 12946096     DOI: 10.1017/s0033291703007815

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  17 in total

1.  The RAISE Connection Program for Early Psychosis: Secondary Outcomes and Mediators and Moderators of Improvement.

Authors:  Leslie Marino; Ilana Nossel; Jean C Choi; Keith Nuechterlein; Yuanjia Wang; Susan Essock; Melanie Bennett; Karen McNamara; Sapna Mendon; Lisa Dixon
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

2.  Untreated illness and recovery in clients of an early psychosis intervention program: a 10-year prospective cohort study.

Authors:  Gina Bhullar; Ross M G Norman; Neil Klar; Kelly K Anderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-11-29       Impact factor: 4.328

3.  Negative symptoms in individuals at clinical high risk of psychosis.

Authors:  Danijela Piskulic; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Thomas H McGlashan
Journal:  Psychiatry Res       Date:  2012-03-22       Impact factor: 3.222

4.  A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia.

Authors:  Shannon M Couture; Eric L Granholm; Scott C Fish
Journal:  Schizophr Res       Date:  2010-10-20       Impact factor: 4.939

5.  Quality of life in first episode psychosis: a cluster analytic approach.

Authors:  Z Liao; K Allott; J F I Anderson; E Killackey; S M Cotton
Journal:  Qual Life Res       Date:  2021-10-18       Impact factor: 4.147

6.  Determinants of objective and subjective quality of life in first-time-admission schizophrenic patients in Poland: a longitudinal study.

Authors:  Krystyna Górna; Krystyna Jaracz; Filip Rybakowski; Janusz Rybakowski
Journal:  Qual Life Res       Date:  2007-12-28       Impact factor: 4.147

7.  Social functioning in urban, predominantly African American, socially disadvantaged patients with first-episode nonaffective psychosis.

Authors:  Sandra M Goulding; Lauren Franz; Erin Bergner; Michael T Compton
Journal:  Schizophr Res       Date:  2010-01-08       Impact factor: 4.939

8.  Social cognition mediates illness-related and cognitive influences on social function in patients with schizophrenia-spectrum disorders.

Authors:  Jean Addington; Todd A Girard; Bruce K Christensen; Donald Addington
Journal:  J Psychiatry Neurosci       Date:  2010-01       Impact factor: 6.186

Review 9.  Schizophrenia outcomes in the 21st century: A systematic review.

Authors:  Peter Huxley; Anne Krayer; Rob Poole; Louise Prendergast; Sanjaya Aryal; Richard Warner
Journal:  Brain Behav       Date:  2021-05-15       Impact factor: 2.708

10.  Integrated treatment to achieve functional recovery for first-episode psychosis.

Authors:  Marcelo Valencia; Francisco Juarez; Hector Ortega
Journal:  Schizophr Res Treatment       Date:  2012-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.